scholarly journals Recommendations for the Management of the Incidental Renal Mass in Adults: Endorsement and Adaptation of the 2017 ACR Incidental Findings Committee White Paper by the Canadian Association of Radiologists Incidental Findings Working Group

2019 ◽  
Vol 70 (2) ◽  
pp. 125-133 ◽  
Author(s):  
Iain D.C. Kirkpatrick ◽  
Gary L. Brahm ◽  
Gevork N. Mnatzakanian ◽  
Casey Hurrell ◽  
Brian R. Herts ◽  
...  
Keyword(s):  
Working Group ◽  
Incidental Findings ◽  
Renal Mass ◽  
White Paper ◽  
Canadian Association

scholarly journals Recommendations for the Management of Incidental Pancreatic Findings in Adults by the Canadian Association of Radiologists Incidental Findings Working Group

2021 ◽  
pp. 084653712110210
Author(s):  
Christopher I. Fung ◽  
David L. Bigam ◽  
Clarence K. W. Wong ◽  
Casey Hurrell ◽  
Jeffery R. Bird ◽  
...  
Keyword(s):  
Working Group ◽  
Incidental Findings ◽  
Practice Patterns ◽  
Cost Effective ◽  
Pancreatic Cysts ◽  
Canadian Association ◽  
Pancreatic Calcifications ◽  
Fatty Atrophy ◽  
Anatomic Variants

The Canadian Association of Radiologists Incidental Findings Working Group consists of both academic subspecialty and general radiologists and is tasked with adapting and expanding upon the American College of Radiology incidental findings white papers to more closely apply to Canadian practice patterns, particularly more comprehensively dealing with the role of ultrasound and pursuing more cost-effective approaches to the workup of incidental findings without compromising patient care. Presented here are the 2021 Canadian guidelines for the management of pancreatic incidental findings. Topics covered include anatomic variants, fatty atrophy, pancreatic calcifications, ductal ectasia, and management of incidental pancreatic cysts.

Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee

2018 ◽  
Vol 15 (2) ◽  
pp. 264-273 ◽  
Author(s):  
Brian R. Herts ◽  
Stuart G. Silverman ◽  
Nicole M. Hindman ◽  
Robert G. Uzzo ◽  
Robert P. Hartman ◽  
...  
Keyword(s):  
Incidental Findings ◽  
Renal Mass ◽  
White Paper

scholarly journals Canadian Association of Radiologists White Paper on Artificial Intelligence in Radiology

2018 ◽  
Vol 69 (2) ◽  
pp. 120-135 ◽  
Author(s):  
An Tang ◽  
Roger Tam ◽  
Alexandre Cadrin-Chênevert ◽  
Will Guest ◽  
Jaron Chong ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Patient Care ◽  
Working Group ◽  
White Paper ◽  
Patient Centered ◽  
Computing Power ◽  
Implementation Phase ◽  
Early Adoption ◽  
Canadian Association

Artificial intelligence (AI) is rapidly moving from an experimental phase to an implementation phase in many fields, including medicine. The combination of improved availability of large datasets, increasing computing power, and advances in learning algorithms has created major performance breakthroughs in the development of AI applications. In the last 5 years, AI techniques known as deep learning have delivered rapidly improving performance in image recognition, caption generation, and speech recognition. Radiology, in particular, is a prime candidate for early adoption of these techniques. It is anticipated that the implementation of AI in radiology over the next decade will significantly improve the quality, value, and depth of radiology's contribution to patient care and population health, and will revolutionize radiologists' workflows. The Canadian Association of Radiologists (CAR) is the national voice of radiology committed to promoting the highest standards in patient-centered imaging, lifelong learning, and research. The CAR has created an AI working group with the mandate to discuss and deliberate on practice, policy, and patient care issues related to the introduction and implementation of AI in imaging. This white paper provides recommendations for the CAR derived from deliberations between members of the AI working group. This white paper on AI in radiology will inform CAR members and policymakers on key terminology, educational needs of members, research and development, partnerships, potential clinical applications, implementation, structure and governance, role of radiologists, and potential impact of AI on radiology in Canada.

scholarly journals Recommendations for the Management of Incidental Hepatobiliary Findings in Adults: Endorsement and Adaptation of the 2017 and 2013 ACR Incidental Findings Committee White Papers by the Canadian Association of Radiologists Incidental Findings Working Group

2020 ◽  
Vol 71 (4) ◽  
pp. 437-447
Author(s):  
Jeffery R. Bird ◽  
Gary L. Brahm ◽  
Christopher Fung ◽  
Sunit Sebastian ◽  
Iain D. C. Kirkpatrick
Keyword(s):  
Computed Tomography ◽  
Patient Care ◽  
Working Group ◽  
Incidental Findings ◽  
Practice Patterns ◽  
Cost Effective ◽  
Initial Assessment ◽  
Wall Thickening ◽  
Canadian Association

The Canadian Association of Radiologists Incidental Findings Working Group consists of both academic subspecialty and general radiologists and is tasked with adapting and expanding upon the American College of Radiology incidental findings white papers to more closely apply to Canadian practice patterns, particularly more comprehensively dealing with the role of ultrasound and pursuing more cost-effective approaches to the workup of incidental findings without compromising patient care. Presented here are the 2020 Canadian guidelines for the management of hepatobiliary incidental findings. Topics covered include initial assessment of hepatic steatosis and cirrhosis, the workup of incidental liver masses identified on ultrasound and computed tomography (with algorithms presented), incidental gallbladder findings (wall thickening, calcification, and polyps), and management of incidental biliary dilatation.

Managing Incidental Findings on Abdominal and Pelvic CT and MRI, Part 2: White Paper of the ACR Incidental Findings Committee II on Vascular Findings

2013 ◽  
Vol 10 (10) ◽  
pp. 789-794 ◽  
Author(s):  
Faisal Khosa ◽  
Glenn Krinsky ◽  
Michael Macari ◽  
E. Kent Yucel ◽  
Lincoln L. Berland
Keyword(s):  
Incidental Findings ◽  
White Paper ◽  
Ct And Mri

scholarly journals Canadian Association of Radiologists Recommendations for the Safe Use of MRI During Pregnancy

2021 ◽  
pp. 084653712110156
Author(s):  
Pejman Jabehdar Maralani ◽  
Anish Kapadia ◽  
Grace Liu ◽  
Felipe Moretti ◽  
Hournaz Ghandehari ◽  
...  
Keyword(s):  
Working Group ◽  
Energy Deposition ◽  
Expert Panel ◽  
Acoustic Noise ◽  
Evidence Based ◽  
Resonance Imaging ◽  
Canadian Association ◽  
Fetal Safety ◽  
Magnetic Resonance Imaging Mri ◽  
In Pregnancy

The use of magnetic resonance imaging (MRI) during pregnancy is associated with concerns among patients and health professionals with regards to fetal safety. In this work, the Canadian Association of Radiologists (CAR) Working Group on MRI in Pregnancy presents recommendations for the use of MRI in pregnancy, derived from literature review as well as expert panel opinions and discussions. The working group, which consists of academic subspecialty radiologists and obstetrician-gynaecologists, aimed to provide updated, evidence-based recommendations addressing safety domains related to energy deposition, acoustic noise, and gadolinium-based contrast agent use based on magnetic field strength (1.5T and 3T) and trimester scanned, in addition to the effects of sedative use and occupational exposure.

Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee

2017 ◽  
Vol 14 (7) ◽  
pp. 911-923 ◽  
Author(s):  
Alec J. Megibow ◽  
Mark E. Baker ◽  
Desiree E. Morgan ◽  
Ihab R. Kamel ◽  
Dushyant V. Sahani ◽  
...  
Keyword(s):  
Incidental Findings ◽  
White Paper ◽  
Pancreatic Cysts ◽  
Incidental Pancreatic Cysts

Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies

2010 ◽  
Vol 2 (4) ◽  
pp. 435-454 ◽  
Author(s):  
José Pinheiro ◽  
Frederic Sax ◽  
Zoran Antonijevic ◽  
Björn Bornkamp ◽  
Frank Bretz ◽  
...  
Keyword(s):  
Quantitative Evaluation ◽  
Working Group ◽  
White Paper ◽  
Model Based ◽  
Dose Ranging

scholarly journals Gadolinium Deposition in the Brain: A Systematic Review of Existing Guidelines and Policy Statement Issued by the Canadian Association of Radiologists

2018 ◽  
Vol 69 (4) ◽  
pp. 373-382 ◽  
Author(s):  
Andreu F. Costa ◽  
Christian B. van der Pol ◽  
Pejman Jabehdar Maralani ◽  
Matthew D.F. McInnes ◽  
Jason R. Shewchuk ◽  
...  
Keyword(s):  
Systematic Review ◽  
Working Group ◽  
Conclusive Evidence ◽  
Severe Allergic Reaction ◽  
Policy Statement ◽  
Hepatobiliary Phase ◽  
Phase Imaging ◽  
Gadolinium Deposition ◽  
Canadian Association ◽  
The Brain

Emerging evidence has confirmed that, following administration of a gadolinium-based contrast agent (GBCA), very small amounts of gadolinium will deposit in the brain of humans with intact blood-brain barriers. The literature is evolving rapidly and the degree to which gadolinium will deposit for a particular GBCA or class of GBCAs remains undetermined. Several studies suggest that linear GBCAs deposit more gadolinium in the brain compared with macrocyclic GBCAs; however, our understanding of the molecular composition of deposited gadolinium is preliminary, and the clinical significance of gadolinium deposition remains unknown. To date, there is no conclusive evidence linking gadolinium deposition in the brain with any adverse patient outcome. A panel of radiologists representing the Canadian Association of Radiologists was assembled to assist the Canadian medical imaging community in making informed decisions regarding the issue of gadolinium deposition in the brain. The objectives of the working group were: 1) to review the evidence from animal and human studies; 2) to systematically review existing guidelines and position statements issued by other organizations and health agencies; and 3) to formulate an evidence-based position statement on behalf of the Canadian Association of Radiologists. Based on our appraisal of the evidence and systematic review of 9 guidelines issued by other organizations, the working group established the following consensus statement. GBCA administration should be considered carefully with respect to potential risks and benefits, and only used when required. Standard dosing should be used and repeat administrations should be avoided unless necessary. Gadolinium deposition is one of several issues to consider when prescribing a particular GBCA. Currently there is insufficient evidence to recommend one class of GBCA over another. The panel considered it inappropriate to withhold a linear GBCA if a macrocyclic agent is unavailable, if hepatobiliary phase imaging is required, or if there is a history of severe allergic reaction to a macrocyclic GBCA. Further study in this area is required, and the evidence should be monitored regularly with policy statements updated accordingly.

Sign in / Sign up

Export Citation Format

Share Document